This is a routine board change with no immediate trading signal. Monitor the company's next filing for capital-raising updates or clinical milestones for vebreltinib, given the going-concern risk highlighted in the prior 20-F.
Price Chart
Executive Summary
Apollomics Inc. reported the resignation of two directors (Yi-An Chu and Dr. Chen-Huan Jan) and the appointment of Hung-Hsien Yen as a Class I director, effective July 20, 2026. The board now has six members, with four independent directors. This is a routine governance change with no material financial impact, though the company faces a going-concern risk per its recent 20-F filing, which reported a net loss of $10.9 million and only $3.3 million in cash.
Key Facts
- Two directors resigned on July 20, 2026, with no disagreement with the company.
- Hung-Hsien Yen appointed as Class I director, Audit Committee member, and Nominating and Corporate Governance Committee Chairman.
- New director has over 25 years of private equity and investment experience.
- Board now has six members, including four independent directors.
- New director receives 500 RSUs vesting September 15, 2026, plus annual cash compensation of $39,000.
Financial Impact
New director compensation: 500 RSUs and $39,000 in annual cash retainer and fees — immaterial relative to the company's cash position.
Risk Factors
- Board changes may signal governance instability, though resignations were stated as unrelated to disagreements.
- Company faces substantial doubt about its ability to continue as a going concern, per the prior 20-F filing.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001193125-26-310154 |
| Document: 0001193125-26-310154-index-headers.html | 0001193125-26-310154 |
| Document: 0001193125-26-310154-index.html | 0001193125-26-310154 |
| Document: 0001193125-26-310154.txt | 0001193125-26-310154 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 17, 2026 9w ago | Insider Cluster | $23.92 $26.50 | ▲ +10.79% | ▲ +10.99% | $21.84 (−8.70%) |
Aug 17, 2026 9w ago | Insider Cluster | $23.92 $26.50 | ▲ +10.79% | ▲ +10.99% | $21.84 (−8.70%) |
Aug 17, 2026 9w ago | Insider Cluster | $23.92 $26.50 | ▲ +10.79% | ▲ +10.99% | $21.84 (−8.70%) |
Aug 17, 2026 9w ago | Insider Cluster | $23.92 $26.50 | ▲ +10.79% | ▲ +10.99% | $21.84 (−8.70%) |
Jul 21, 2026 13w ago | 6-K | $18.71 $18.00 | ▼ −3.77% | ▼ −2.54% | $21.84 (+16.76%) |
Jul 14, 2026 14w ago | 6-K | $15.70 $18.86 | ▲ +20.13% | ▲ +21.42% | $21.84 (+39.11%) |
Jun 24, 2026 17w ago | 6-K | $22.00 $20.16 | ▲ +8.36% | ▲ +9.92% | $21.84 (+0.73%) |
Apr 27, 2026 26w ago | Press Release | $13.19 $16.47 | ▲ +24.84% | ▲ +24.44% | $21.84 (+65.58%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers